GOG Foundation GOG 3018/VB-111-701

Primary Category:

Treatment Protocols

Disease Category:

Gynecologic, Ovarian

Status:

New, Open

The OVAL Study: A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs. Paclitaxel Combined with Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer

NCT#03398655